Cita APA

Katz, E. G., Hough, D., Doherty, T., Lane, R., Singh, J., & Levitan, B. (2020). Benefit–Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment‐Resistant Depression. Clin Pharmacol Ther.

Citación estilo Chicago

Katz, Eva G., David Hough, Teodora Doherty, Rosanne Lane, Jaskaran Singh, y Bennett Levitan. "Benefit–Risk Assessment of Esketamine Nasal Spray Vs. Placebo in Treatment‐Resistant Depression." Clin Pharmacol Ther 2020.

Cita MLA

Katz, Eva G., et al. "Benefit–Risk Assessment of Esketamine Nasal Spray Vs. Placebo in Treatment‐Resistant Depression." Clin Pharmacol Ther 2020.